Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Digital Therapeutics Market Status and Forecast (2017-2028)
  • 1.3.2 Global Digital Therapeutics Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Digital Therapeutics Supply by Company

• 2.1 Global Digital Therapeutics Sales Volume by Company
• 2.2 Global Digital Therapeutics Sales Value by Company
• 2.3 Global Digital Therapeutics Price by Company
• 2.4 Digital Therapeutics Production Location and Sales Area of Main Manufacturers
• 2.5 Trend of Concentration Rate

3 Global and Regional Digital Therapeutics Market Status by Type

• 3.1 Digital Therapeutics Type Introduction
  • 3.1.1 Software
  • 3.1.2 Devices
• 3.2 Global Digital Therapeutics Market by Type
  • 3.2.1 Global Digital Therapeutics Sales Volume by Type (2017-2022)
  • 3.2.2 Global Digital Therapeutics Sales Value by Type (2017-2022)
  • 3.2.3 Global Digital Therapeutics Price by Type (2017-2022)
• 3.3 North America: by Type
• 3.4 Europe: by Type
• 3.5 Asia Pacific: by Type
• 3.6 Central & South America: by Type
• 3.7 Middle East & Africa: by Type

4 Global and Regional Digital Therapeutics Market Status by Application

• 4.1 Digital Therapeutics Segment by Application
  • 4.1.1 Diabetes
  • 4.1.2 Obesity
  • 4.1.3 Cardio Vascular Diseases (CVD)
  • 4.1.4 Central Nervous System (CNS) Disease
  • 4.1.5 Gastrointestinal Disorders (GID)
  • 4.1.6 Respiratory Diseases
  • 4.1.7 Smoking Cessation
  • 4.1.8 Others
• 4.2 Global Digital Therapeutics Market by Application
  • 4.2.1 Global Digital Therapeutics Sales Volume by Application (2017-2022)
  • 4.2.2 Global Digital Therapeutics Sales Value by Application (2017-2022)
  • 4.2.3 Global Digital Therapeutics Price by Application (2017-2022)
• 4.3 North America: by Application
• 4.4 Europe: by Application
• 4.5 Asia Pacific: by Application
• 4.6 Central & South America: by Application
• 4.7 Middle East & Africa: by Application

5 Global Digital Therapeutics Market Status by Region

• 5.1 Global Digital Therapeutics Market by Region
  • 5.1.1 Global Digital Therapeutics Sales Volume by Region
  • 5.1.2 Global Digital Therapeutics Sales Value by Region
• 5.2 North America Digital Therapeutics Market Status
• 5.3 Europe Digital Therapeutics Market Status
• 5.4 Asia Pacific Digital Therapeutics Market Status
• 5.5 Central & South America Digital Therapeutics Market Status
• 5.6 Middle East & Africa Digital Therapeutics Market Status

6 North America Digital Therapeutics Market Status

• 6.1 North America Digital Therapeutics Market by Country
  • 6.1.1 North America Digital Therapeutics Sales Volume by Country (2017-2022)
  • 6.1.2 North America Digital Therapeutics Sales Value by Country (2017-2022)
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Digital Therapeutics Market Status

• 7.1 Europe Digital Therapeutics Market by Country
  • 7.1.1 Europe Digital Therapeutics Sales Volume by Country (2017-2022)
  • 7.1.2 Europe Digital Therapeutics Sales Value by Country (2017-2022)
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Digital Therapeutics Market Status

• 8.1 Asia Pacific Digital Therapeutics Market by Country
  • 8.1.1 Asia Pacific Digital Therapeutics Sales Volume by Country (2017-2022)
  • 8.1.2 Asia Pacific Digital Therapeutics Sales Value by Country (2017-2022)
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Digital Therapeutics Market Status

• 9.1 Central & South America Digital Therapeutics Market by Country
  • 9.1.1 Central & South America Digital Therapeutics Sales Volume by Country (2017-2022)
  • 9.1.2 Central & South America Digital Therapeutics Sales Value by Country (2017-2022)
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Digital Therapeutics Market Status

• 10.1 Middle East & Africa Digital Therapeutics Market by Country
  • 10.1.1 Middle East & Africa Digital Therapeutics Sales Volume by Country (2017-2022)
  • 10.1.2 Middle East & Africa Digital Therapeutics Sales Value by Country (2017-2022)
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Supply Chain and Manufacturing Cost Analysis

• 11.1 Supply Chain Analysis
• 11.2 Production Process Chart Analysis
• 11.3 Raw Materials and Key Suppliers Analysis
  • 11.3.1 Raw Materials Introduction
  • 11.3.2 Raw Materials Key Suppliers List
• 11.4 Digital Therapeutics Manufacturing Cost Analysis
• 11.5 Digital Therapeutics Sales Channel and Distributors Analysis
  • 11.5.1 Digital Therapeutics Sales Channel
  • 11.5.2 Digital Therapeutics Distributors
• 11.6 Digital Therapeutics Downstream Major Buyers

12 Global Digital Therapeutics Market Forecast by Type and by Application

• 12.1 Global Digital Therapeutics Sales Volume and Sales Value Forecast (2023-2028)
• 12.2 Global Digital Therapeutics Forecast by Type
  • 12.2.1 Global Digital Therapeutics Sales Volume Forecast by Type
  • 12.2.2 Global Digital Therapeutics Sales Value Forecast by Type
  • 12.2.3 Global Digital Therapeutics Price Forecast by Type
• 12.3 Global Digital Therapeutics Forecast by Application
  • 12.3.1 Global Digital Therapeutics Sales Volume Forecast by Application
  • 12.3.2 Global Digital Therapeutics Sales Value Forecast by Application
  • 12.3.3 Global Digital Therapeutics Price Forecast by Application

13 Global Digital Therapeutics Market Forecast by Region/Country

• 13.1 Global Digital Therapeutics Market Forecast by Region (2023-2028)
  • 13.1.1 Global Digital Therapeutics Sales Volume Forecast by Region (2023-2028)
  • 13.1.2 Global Digital Therapeutics Sales Value Forecast by Region (2023-2028)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 WellDoc
  • 14.1.1 Company Information
  • 14.1.2 Digital Therapeutics Product Introduction
  • 14.1.3 WellDoc Digital Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
  • 14.1.4 SWOT Analysis
• 14.2 Twine Health
  • 14.2.1 Company Information
  • 14.2.2 Digital Therapeutics Product Introduction
  • 14.2.3 Twine Health Digital Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
  • 14.2.4 SWOT Analysis
• 14.3 Proteus Digital Health
  • 14.3.1 Company Information
  • 14.3.2 Digital Therapeutics Product Introduction
  • 14.3.3 Proteus Digital Health Digital Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
  • 14.3.4 SWOT Analysis
• 14.4 Propeller Health
  • 14.4.1 Company Information
  • 14.4.2 Digital Therapeutics Product Introduction
  • 14.4.3 Propeller Health Digital Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
  • 14.4.4 SWOT Analysis
• 14.5 Omada Health
  • 14.5.1 Company Information
  • 14.5.2 Digital Therapeutics Product Introduction
  • 14.5.3 Omada Health Digital Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
  • 14.5.4 SWOT Analysis
• 14.6 Livongo Health
  • 14.6.1 Company Information
  • 14.6.2 Digital Therapeutics Product Introduction
  • 14.6.3 Livongo Health Digital Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
  • 14.6.4 SWOT Analysis
• 14.7 Canary Health
  • 14.7.1 Company Information
  • 14.7.2 Digital Therapeutics Product Introduction
  • 14.7.3 Canary Health Digital Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
  • 14.7.4 SWOT Analysis
• 14.8 2Morrow
  • 14.8.1 Company Information
  • 14.8.2 Digital Therapeutics Product Introduction
  • 14.8.3 2Morrow Digital Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
  • 14.8.4 SWOT Analysis

15 Conclusion

16 Methodology

This report provides a comprehensive analysis of current global Digital Therapeutics market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Digital Therapeutics industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Digital Therapeutics market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Digital Therapeutics Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Digital Therapeutics market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Digital Therapeutics Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Digital Therapeutics industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Software
Devices

Segmented by Application
Diabetes
Obesity
Cardio Vascular Diseases (CVD)
Central Nervous System (CNS) Disease
Gastrointestinal Disorders (GID)
Respiratory Diseases
Smoking Cessation
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Proteus Digital Health
Propeller Health
Omada Health
Livongo Health
Canary Health
2Morrow